Slide 1: Preliminary H1 2024 Results Presentation
• PRELIMINARY H1 2024 RESULTS PRESENTATION • August 8th, 2024
Slide 2: Executive Summary
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Executive Summary H1 2024 key trends and figures H1 2024 Sales at €214.8m, +1.6% excluding FX vs. H1 2023, in line with Q1 performance €52.0m adjusted EBITDA in
Slide 3: H1 2024 Results At-a-Glance
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx H1 2024 Results At-a-Glance Organic growth and deleverage on-track with targets, rising profitability SALES Adjusted EBITDA and % Adjusted NFP and Leverage €m O
Slide 4: Sales – H1 2024 vs. H1 2023
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Sales – H1 2024 vs. H1 2023 +1.6% YoY organic growth, supported by pricing and volume recovery SALES – H1 2023 TO H1 2024 BRIDGE €m • +1.6% organic growth 2. 21
Slide 5: Sales – H1 2024 Performance by Division
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Sales – H1 2024 Performance by Division Healthcare back to growth, strong Safety order momentum continues Healthcare & Life Sciences Health & Safety Energy & Mo
Slide 6: Adj. EBITDA Margin – Q-on-Q Evolution
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Adj. EBITDA Margin – Q-on-Q Evolution Q-on-Q profitability recovery continues ADJ. EBITDA MARGIN – Q3 2022 – Q2 2024 QUARTERLY EVOLUTION €m 25.0% 23.3% 23.4% 22
Slide 7: Adj. EBITDA – H1 2024 vs. H1 2023
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Adj. EBITDA – H1 2024 vs. H1 2023 +11.5% YoY organic growth excl. FX ADJ. EBITDA – H1 2023 TO H1 2024 BRIDGE €m 22.1% ADJUSTED EBITDA % 24.2% 210 bps of margin
Slide 8: Adj. Net Income – H1 2024 vs. H1 2023
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Adj. Net Income – H1 2024 vs. H1 2023 +12.3% YoY growth excl. FX impact Adj. Net Income Adj. Net Income Excl. FX Gains/Losses €m €m +12.3% +50.3% 24.8 22.5 20.0
Slide 9: Adj. Net Financial Position – H1 2024 vs. FY 2023
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Adj. Net Financial Position – H1 2024 vs. FY 2023 Limited NWC absorption, extraordinary Capex for the new Chinese plant ADJUSTED NET FINANCIAL POSITION – FY 202
Slide 10: 2024 Outlook and Guidance
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx 2024 Outlook and Guidance Volume recovery to accelerate in Q3 2024, guidance revised upwards Q3 2024: expected high-single digit sales growth vs. Q3 2023, thank
Slide 11: Disclaimer
ibdroot\projects\IBD-LN\fiberglass2019\643420_1\7. Marketing Materials\03 Analyst Presentation\Project Vicky_Analyst Presentation_ v55.pptx Disclaimer Pursuant to art. 154-bis, paragraph 2, of the Italian Unified Financial Act of February 24, 1998, the executive in charge of preparing the corporate